GL1X · GenesisL1 explorer

MolNFT v1 · #37410 · protein

Structure-based drug design of a novel family of ppar partial agonists: virtual screening, X-ray crystallography and in VITRO/IN vivo biological activities

2G0G · Peroxisome proliferator-activated receptor gamma: “Structure-based drug design of a novel family of ppar partial agonists: virtual screening, X-ray…”. X-ray diffraction, 1 ligand (SP0), 5 pockets (best druggability 0.86). MolNFT v1…

PDB
2G0G
Type
protein
Length
542 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
SP0
Pockets
5 · best druggability 0.86

Structure

x-ray diffraction · 1 distinct chain · 63% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPeroxisome proliferator-activated receptor gammaprotein27163% helix, 4% strandP37231

Ligands and binding sites

  • SP0 · 3-fluoro-N-[1-(4-fluorophenyl)-3-(2-thienyl)-1H-pyrazol-5-yl]benzenesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18080.860.8876SP0
24030.810.8954empty
37420.770.8181empty
4620.320.7515empty
5540.250.7210empty

Interfaces

1 interface between chains.

  • A–B · 836 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2G0G · Structure-based drug design of a novel family of PPAR partial agonists: virtual… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.